Fu Han Selected Research

Fu Han Research Topics

Disease

9	Wounds and Injuries (Trauma) 01/2022 - 08/2010
9	Inflammation (Inflammations) 01/2021 - 01/2018
6	Sepsis (Septicemia) 10/2020 - 01/2018
3	Hypoxia (Hypoxemia) 10/2020 - 06/2018
2	Burns 01/2021 - 04/2014
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2019 - 06/2018
2	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2019 - 08/2018
2	Fibrosis (Cirrhosis) 01/2019 - 10/2014
2	Cicatrix (Scar) 08/2018 - 01/2018
2	Neoplasms (Cancer) 06/2018 - 01/2017
2	Body Weight (Weight, Body) 01/2017 - 10/2013
1	Ependymoma 01/2022
1	Systemic Inflammatory Response Syndrome (Sepsis Syndrome) 01/2021
1	Acute Lung Injury 10/2020
1	Chronic Renal Insufficiency 10/2020
1	Lung Injury 10/2020
1	Anemia 10/2020
1	Hyperglycemia 01/2019
1	Ischemia 01/2019
1	Ulcer 01/2019
1	Colorectal Neoplasms (Colorectal Cancer) 06/2018
1	Prostatic Neoplasms (Prostate Cancer) 06/2018
1	Infections 04/2018
1	Keloid 04/2018
1	Wound Infection (Wound Infections) 04/2017
1	Glioma (Gliomas) 01/2017
1	Chronic Hepatitis B 05/2015
1	Hypothermia 08/2007
1	Traumatic Brain Injuries (Traumatic Brain Injury) 08/2007

Drug/Important Bio-Agent (IBA)

6	Sirtuin 1IBA 01/2021 - 01/2018
4	Proteins (Proteins, Gene)FDA Link 01/2019 - 10/2014
3	Messenger RNA (mRNA)IBA 01/2022 - 10/2014
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2019 - 06/2018
3	CurcuminIBA 01/2019 - 01/2017
3	CollagenIBA 01/2019 - 10/2014
3	LipopolysaccharidesIBA 10/2018 - 01/2018
2	Adenosine Triphosphate (ATP)IBA 01/2019 - 06/2018
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	sirtinolIBA 01/2021
1	Prolyl-Hydroxylase InhibitorsIBA 10/2020
1	roxadustatIBA 10/2020
1	SRT1720IBA 01/2019
1	AntioxidantsIBA 01/2019
1	Lysine (L-Lysine)FDA Link 01/2019
1	Pentoxifylline (Trental)FDA LinkGeneric 01/2019
1	NF-kappa B (NF-kB)IBA 01/2019
1	XanthineIBA 01/2019
1	indium-bleomycinIBA 01/2019
1	MicroRNAs (MicroRNA)IBA 10/2018
1	Peptide Hydrolases (Proteases)FDA Link 06/2018
1	Therapeutic UsesIBA 06/2018
1	WD repeat containing planar cell polarity effectorIBA 04/2018
1	CateninsIBA 04/2018
1	DNA (Deoxyribonucleic Acid)IBA 04/2018
1	Complementary DNA (cDNA)IBA 04/2018
1	LuciferasesIBA 04/2018
1	Decitabine FDA Link 04/2018
1	Long Noncoding RNAIBA 03/2018
1	CytokinesIBA 03/2018
1	TNF Receptor-Associated Factor 6 (TRAF6)IBA 01/2018
1	Deubiquitinating EnzymesIBA 01/2018
1	Small Interfering RNA (siRNA)IBA 01/2018
1	Thrombospondin 1IBA 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	Angiopoietin-2IBA 01/2017
1	InterleukinsIBA 05/2015
1	Interleukin-10 (Interleukin 10)IBA 10/2014
1	AntagomirsIBA 10/2014
1	Caspase 3 (Caspase-3)IBA 04/2014
1	Glucose (Dextrose)FDA LinkGeneric 10/2013
1	Blood Glucose (Blood Sugar)IBA 10/2013
1	CalpainIBA 08/2007

Therapy/Procedure

5	Therapeutics 08/2018 - 10/2013
1	Biological Therapy 01/2020
1	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2019
1	Surgical Amputation (Amputations) 01/2019
1	Myocutaneous Flap 04/2017
1	Aftercare (After-Treatment) 01/2017
1	Negative-Pressure Wound Therapy 10/2013
1	Lasers (Laser) 10/2013
1	Transplantation 10/2012
1	Length of Stay 08/2010
1	Free Tissue Flaps 08/2010